Frontlight ResearchEarly access
Trial site
Kings College London
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Migraine2 trials
- Coronary artery disease1 trial
- HIV1 trial
- Insomnia1 trial
- Parkinson disease1 trial
- Prostate cancer1 trial
- Sickle cell disease1 trial
- Spinal muscular atrophy1 trial
- Thalassaemia1 trial
- Phase
- Phase 32 trials
- Phase 42 trials
- Phase 21 trial
- Status
- Completed4 trials
- Not yet recruiting2 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Lead sponsor
- Pfizer2 trials
- Forma Therapeutics, Inc.1 trial
- Imperial College London1 trial
- King's College London1 trial
- NEAT ID Foundation1 trial
- and 3 more
Running trials
Not yet recruiting
Recruiting
Service Evaluation for Newborn Screening for Spinal Muscular Atrophy
Enrolling by invitation
Recruiting
Recruiting
Imperial Prostate 9 - ATLAS (Approaches To Long-Term Active Surveillance)
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Coronary artery disease1 recruiting
- Insomnia1 recruiting
- Parkinson disease1 recruiting
- Prostate cancer1 recruiting
- Spinal muscular atrophy1 recruiting
Closed trials
Completed
Completed
Completed
A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease
Completed
Site data: ClinicalTrials.govUpdated 13 Nov 2026